Literature DB >> 17611970

Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease.

Gordon K Lam, Laura K Hummers, Adrianne Woods, Fredrick M Wigley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17611970

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  20 in total

Review 1.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension.

Authors:  Todd M Kolb; Rachel L Damico; Paul M Hassoun
Journal:  J Mol Med (Berl)       Date:  2011-08       Impact factor: 4.599

Review 3.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 4.  Update on systemic sclerosis.

Authors:  Courtney J McCray; Maureen D Mayes
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 5.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

Review 6.  Scleroderma therapy: clinical overview of current trends and future perspective.

Authors:  Afsha A Topal; Rachita S Dhurat
Journal:  Rheumatol Int       Date:  2012-08-03       Impact factor: 2.631

7.  Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases.

Authors:  Dinesh Khanna; Harsh Agrawal; Philip J Clements
Journal:  Rheumatology (Oxford)       Date:  2010-03-22       Impact factor: 7.580

8.  [Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality].

Authors:  M O Becker; U Müller-Ladner; G Riemekasten
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

Review 9.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

10.  Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.

Authors:  Thomas Hügle; Steven O'Reilly; Rachel Simpson; Marina D Kraaij; Venetia Bigley; Matthew Collin; Anja Krippner-Heidenreich; Jacob M van Laar
Journal:  Arthritis Rheum       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.